Author:
Nedelea Irena,Dobrican-Băruţa Carmen-Teodora,Bălan Radu-Gheorghe,Muntean Adriana,Deleanu Diana
Reference47 articles.
1. Blank S, Grosch J, Ollert M, Bilò MB. Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes. Front Immunol. 2020;11:579409. doi: 10.3389/fimmu.2020.579409.
2. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy. 2005;60(4):443–51. doi: 10.1111/j.1398-9995.2005.00785.x.
3. Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp. 2004;257:116–28; discussion 28-32, 57-60, 276-85. doi: 10.1002/ 0470861193.ch10.
4. Worm M, Moneret-Vautrin A, Scherer K, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69(10):1397-1404. doi:10.1111/all.12475.
5. Kosnik M, Korosec P, Silar M, Music E, Erzen R. Wasp venom is appropriate for immunotherapy of patients with allergic reaction to the European hornet sting. Croat Med J. 2002;43(1):25–7.